Mehanna, H., Robinson, M., Hartley, A., Kong, A., Foran, B., Fulton-Lieuw, T., . . . Dunn, J. (2019). Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): An open-label randomised controlled phase 3 trial. Lancet.
シカゴスタイル引用形Mehanna, Hisham, et al. "Radiotherapy Plus Cisplatin or Cetuximab in Low-risk Human Papillomavirus-positive Oropharyngeal Cancer (De-ESCALaTE HPV): An Open-label Randomised Controlled Phase 3 Trial." Lancet 2019.
MLA引用形式Mehanna, Hisham, et al. "Radiotherapy Plus Cisplatin or Cetuximab in Low-risk Human Papillomavirus-positive Oropharyngeal Cancer (De-ESCALaTE HPV): An Open-label Randomised Controlled Phase 3 Trial." Lancet 2019.
警告: この引用は必ずしも正確ではありません.